Thromboprophylaxis After Hip or Knee Arthroplasty

Chan, Noel; Bhandari, Mohit

doi:10.1001/jama.2022.11249

JAMA

2022

DOI: 10.1001/jama.2022.11249

|View full text |Cite

Thromboprophylaxis After Hip or Knee Arthroplasty

Noel Chan

Mohit Bhandari

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 8 publications

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sixth, both Chan and Bhandari and DeMik and colleagues suggest that enoxaparin use may be associated with increased secondary complications (such as bleeding) and that selection of VTE prophylaxis requires assessment of benefits and risks. Statements such as these are misleading.…”

mentioning

confidence: 99%

Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty—Reply

Sidhu¹,

Harris

2023

JAMA

View full text Add to dashboard Cite

for imaging requests were unknown and plausible explanations for high request rates could exist. Serious contemplation of the feedback was likely to benefit, not harm, patients. Furthermore, our study described the use of routinely collected administrative data on volume of imaging requests to generate feedback and study outcomes. We acknowledged that high request rates may not represent inappropriate use in all instances.The team carefully considered the ethical issues of conducting this trial. 4,5 We judged the trial interventions (ie, frequency of feedback [once vs twice] and visual display [standard vs enhanced highlighting of highly requested tests]) as low risk because they involved no more than minimal risk of discomfort or inconvenience compared with standard feedback. Any additional risk of harm to GP participants would be outweighed by the anticipated benefits for patients and for society more broadly from the knowledge gained from the research. The requirement to seek GP consent would make the study unfeasible, and voluntary participation would have limited the generalizability of the findings.The Human Research Ethics Committee at Bond University approved our study and was satisfied that it met requirements for a waiver of consent (clause 2.3.10) of the National Statement on Ethical Conduct in Human Research.

show abstract

mentioning

confidence: 99%

Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty—Reply

Sidhu¹,

Harris

2023

JAMA

View full text Add to dashboard Cite

show abstract

Letter to the editor on “Intraoperative blood loss and haemoglobin drop in patients with developmental dysplasia of the hip in Jordan undergoing total hip arthroplasty”

Liu,

2023

International Orthopaedics (SICOT)

View full text Add to dashboard Cite

Low Molecular Weight Heparin is Superior to Aspirin in the Prevention of Thromboembolic Disease, or is it? Response to an Editorial

Harris

Sidhu

Buchbinder

2023

The Journal of Arthroplasty

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Thromboprophylaxis After Hip or Knee Arthroplasty

Cited by 8 publications

References 15 publications

Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty—Reply

Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty—Reply

Letter to the editor on “Intraoperative blood loss and haemoglobin drop in patients with developmental dysplasia of the hip in Jordan undergoing total hip arthroplasty”

Low Molecular Weight Heparin is Superior to Aspirin in the Prevention of Thromboembolic Disease, or is it? Response to an Editorial

Contact Info

Product

Resources

About